Drug Type Monoclonal antibody |
Synonyms Anti-M-CSF-antibody, MCS-110 |
Target |
Mechanism M-CSF inhibitors(Macrophage Colony Stimulating Factor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationOrphan Drug (US) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Gastric Adenocarcinoma | Phase 2 | KR | 17 Jan 2019 | |
HER2-positive gastric cancer | Phase 2 | KR | 17 Jan 2019 | |
Locally Advanced Melanoma | Phase 2 | US | 10 Sep 2018 | |
Endometrial Carcinoma | Phase 2 | US | 29 Jun 2016 | |
Endometrial Carcinoma | Phase 2 | JP | 29 Jun 2016 | |
Endometrial Carcinoma | Phase 2 | BE | 29 Jun 2016 | |
Endometrial Carcinoma | Phase 2 | FI | 29 Jun 2016 | |
Endometrial Carcinoma | Phase 2 | FR | 29 Jun 2016 | |
Endometrial Carcinoma | Phase 2 | DE | 29 Jun 2016 | |
Endometrial Carcinoma | Phase 2 | HK | 29 Jun 2016 |